Sandra Poole

Companies

• Travere Therapeutics, Inc.Board member May 15, 2019 to now¹
• LogicBio Therapeutics, Inc.Chief operating officer Oct 18, 2018 to Oct 24, 2018²
• ImmunoGen Inc.Senior VP, Tech Operations Sep 22, 2014 to Oct 20, 2016³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TTTravere Therapeutics, Inc. TVTX34,000 shares⁴$1.8M at $53.15May 19, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 19, 2026Granted 4,000 shares of Travere Therapeutics, Inc.⁴
• May 15, 2025Granted 6,500 shares of Travere Therapeutics, Inc.⁵
• May 8, 2024Granted 6,500 shares of Travere Therapeutics, Inc.⁶
• May 17, 2023Granted 4,500 shares of Travere Therapeutics, Inc.⁷
• May 11, 2022Granted 3,000 shares of Travere Therapeutics, Inc.⁸